A Study to Investigate Stannous Fluoride Containing Toothpaste on Antibacterial Effects in the Different Regions of the Mouth
← catalyst calendarNCT07458464 · readout ≤ 42 d
Sponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.
Phase
Phase 3
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
100estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Aug 2026 | estimated | When the study began enrolling |
| Primary completion | Sep 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Sep 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2026-03-09 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-28 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Plaque
- Gingivitis
Interventions
- Drug: stannous fluoride toothpaste
- Drug: 0.76% Sodium Monofluorophosphate (Na MFP) toothpaste
Primary outcomes
what the primary-completion date above is the date OFLoe-Silness
measured baseline, 2 week and 4 week
Turesky Modification of Quigley-Hein
measured baseline, 2 week and 4 week
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed